Duchenne UK and Parent Project Muscular Dystrophy Award $350,000 to Address Immunological Challenges of Gene Therapy in Duchenne Muscular Dystrophy
News provided by
Share this article
Share this article
HACKENSACK, N.J., Feb. 18, 2021 /PRNewswire/ Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), and Duchenne UK, a UK-based patient organization, are pleased to announce Professor Kanneboyina Nagaraju at Binghamton, the State University of New York, as the recipient of their Joint Research Grant Call of 2020. The full title of the research project is
Targeting the innate immune system to block acute inflammatory and chronic immune response to transgene and AAV vector in DMD . Professor Nagaraju s research will receive funding from the organizations in the amount of $350,000.